Skip to content

TLX 5905936P2Recalls & reported problems

Nuvasive, Inc. · TLX20, 9x11x36mm 15° · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00887517958594), received between Oct 20, 2024 and Oct 20, 2024 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Unspecified Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 20, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE EVENT WAS IDENTIFIED DURING A REVIEW OF THE PMCF LUMBAR INTERBODY STUDY, THE REPORT IDENTIFIED THAT ON (B)(6) 2023 A PATIENT UNDERWENT AN ANTERIOR LUMBAR INTERBODY FUSION AND A POSTERIOR INSTRUMENTED FUSION AT L3/4. ON (B)(6) 2023 THE PATIENT UNDERWENT AN L5-S1 EXTREME LATERAL INTERBODY FUSION AT L4/5 AND L5/S1 WITH POSTERIOR FIXATION EXTENDED L4-S1 FOR AN UNRELATED PRE-EXISTING CONDITION. (CONDITION NOT PROVIDED) ON (B)(6) 2023 PATIENT NOTED AND INFECTION WITH DRAINAGE FROM BACK INCISION. ON (B)(6) 2023 THE PATIENT'S INFECTION REQUIRED AN INCISION AND DRAINAGE. ON (B)(6) 2023 THE PATIENT INFECTION WORSENED REQUIRING A PICC LINE PLACED FOR IV ANTIBIOTICS BUT REPORTED AS RESOLVED ON (B)(6) 2024 AS INFECTIOUS DISEASE NOTES NO SIGN OF INFECTION.

    Patient problems: Unspecified Infection

    MAUDE report 20490042 ↗

Other Intervertebral fusion device with bone graft, lumbar devices

All Intervertebral fusion device with bone graft, lumbar devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page